Haemonetics CorporationHAENYSE
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank69
3Y CAGR+10.7%
5Y CAGR-24.7%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
+10.7%/yr
vs -22.1%/yr prior
5Y CAGR
-24.7%/yr
Recent acceleration
Acceleration
+32.8pp
Accelerating
Percentile
P69
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 3.56% |
| Q3 2025 | 1.84% |
| Q2 2025 | -2.78% |
| Q1 2025 | -5.15% |
| Q4 2024 | 0.88% |
| Q3 2024 | 2.78% |
| Q2 2024 | -2.07% |
| Q1 2024 | 2.09% |
| Q4 2023 | 5.68% |
| Q3 2023 | 2.20% |
| Q3 2023 | 2.27% |
| Q1 2023 | -0.29% |
| Q4 2022 | 2.63% |
| Q4 2022 | 13.78% |
| Q3 2022 | -1.34% |
| Q1 2022 | 2.01% |
| Q1 2022 | 8.28% |
| Q4 2021 | 4.97% |
| Q3 2021 | 1.55% |
| Q1 2021 | -6.38% |
| Q4 2020 | 14.74% |
| Q3 2020 | 7.11% |
| Q2 2020 | -17.99% |
| Q1 2020 | -7.91% |
| Q4 2019 | 2.54% |
| Q3 2019 | 5.92% |
| Q2 2019 | -4.35% |
| Q1 2019 | 0.78% |
| Q4 2018 | 2.39% |
| Q3 2018 | 5.33% |
| Q2 2018 | -1.80% |
| Q1 2018 | -0.21% |
| Q4 2017 | 3.85% |
| Q3 2017 | 6.84% |
| Q3 2017 | -7.50% |
| Q1 2017 | 0.10% |
| Q4 2016 | 3.45% |
| Q4 2016 | 4.90% |
| Q3 2016 | -13.36% |
| Q1 2016 | 3.84% |